Tenvir 300 mg – Composition, Uses and Medicine Enquiries
Product Overview
Tenvir 300 mg contains Tenofovir disoproxil fumarate, an antiviral medicine belonging to the nucleotide reverse transcriptase inhibitor category. It works by blocking an enzyme that certain viruses need to reproduce.
Tenofovir disoproxil fumarate is used as part of combination antiretroviral therapy for HIV-1 infection. It may also be prescribed for chronic hepatitis B, depending on the approved product label and the patient’s clinical condition.
For HIV-1 infection, Tenvir should be used with other appropriate antiretroviral medicines and is not intended to be used alone. Treatment decisions depend on the patient’s diagnosis, medical history, kidney function, other medicines and the assessment of a qualified healthcare professional.
Composition and Strength
The supplied product information identifies the following composition:
| Active Ingredient | Strength |
|---|---|
| Tenofovir disoproxil fumarate | 300 mg |
Brand Name: Tenvir
Generic Name: Tenofovir disoproxil fumarate
Strength: 300 mg
Please verify the exact formulation, dosage form and manufacturer details against the original product packaging before proceeding with an enquiry.
Therapeutic Category and Indication
Tenvir 300 mg belongs to the antiviral medicine category and is classified as a nucleotide reverse transcriptase inhibitor (NRTI).
Its clinical use may relate to the following conditions, subject to the approved product information:
- HIV-1 infection, as part of combination antiretroviral therapy.
- Chronic hepatitis B, where approved.
Tenofovir disoproxil fumarate works by interfering with viral replication. For HIV treatment, it must be used with other appropriate antiretroviral medicines and should not be considered a standalone treatment.
The exact approved indications, treatment restrictions and prescribing requirements depend on the specific product label and the applicable regulations in the destination country. A qualified healthcare professional must assess whether the medicine is appropriate for an individual patient.
Administration Information
Tenvir 300 mg should be taken orally according to the instructions provided by the prescribing healthcare professional.
For HIV-1 infection, it should be used with other appropriate antiretroviral medicines as part of a prescribed combination treatment regimen.
Patients should follow the prescribed schedule and should not change the dose, interrupt treatment or substitute medicines without consulting their healthcare professional.
Kidney function, hepatitis B status and potential interactions with other medicines may require clinical assessment and monitoring. The prescribed schedule, duration, missed-dose instructions and monitoring requirements must be provided by the treating clinician.
Website information should not be used to start, switch or stop prescription treatment.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: Tenvir 300 mg
- Generic Name: Tenofovir disoproxil fumarate
- Strength: 300 mg
- Therapeutic Category: Antiviral
- Medicine Class: Nucleotide Reverse Transcriptase Inhibitor
- Indications: HIV-1 infection; chronic hepatitis B where approved.
The dosage form, company name, manufacturer, pack size and actual product presentation must be confirmed against the manufacturer’s labelled packaging.
Available packaging, batch identification, expiry date and remaining shelf life may vary and should be confirmed by an authorised supplier before any transaction.
A product listing does not confirm current stock, price, availability or eligibility for supply to a particular destination.
Prescription and Patient Safety
Tenvir 300 mg is a prescription antiviral medicine and should be used under the supervision of an appropriately qualified healthcare professional.
Kidney function may need to be assessed before and during treatment, as clinically appropriate. Patients should inform their healthcare professional about existing medical conditions and all other medicines they are taking so that potential interactions and treatment-related risks can be evaluated.
Patients with hepatitis B should receive appropriate clinical guidance before interrupting treatment. Stopping tenofovir disoproxil fumarate in people with chronic hepatitis B can lead to a worsening of hepatitis, so treatment changes require medical supervision.
For HIV-1 infection, Tenvir must be used as part of an appropriate combination antiretroviral regimen and not as a standalone treatment.
The exact precautions, monitoring requirements and possible adverse effects should be checked against the current approved product information. Patients should not start, switch or discontinue treatment based solely on website information.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal provides medicine information, product identification and enquiry coordination. Where appropriate, Medinglobal may help patients, caregivers and eligible healthcare organisations communicate with independent, appropriately authorised pharmaceutical suppliers or service providers.
Medinglobal does not manufacture, stock, sell, dispense or prescribe Tenvir through the website. Any regulated pharmaceutical activity, including prescription verification and lawful supply, remains the responsibility of the relevant independent provider and is subject to applicable laws and regulations.
Availability, prescription requirements, lawful supply routes, supporting documents and destination-country restrictions must be confirmed before any transaction. Submitting an enquiry does not guarantee supply or availability.
How to Submit a Tenvir 300 mg Enquiry
To help identify the requested product, include the following details when submitting an enquiry:
- Product or brand name: Tenvir 300 mg.
- Generic name: Tenofovir disoproxil fumarate.
- Required strength and dosage form.
- Required quantity.
- Destination country.
- Prescription or supporting documentation, where applicable.
Medinglobal may review the submitted details for identification and coordination purposes and, where appropriate, refer the enquiry to an authorised independent provider. The provider is responsible for its own verification, regulatory checks and any subsequent supply decision.
Frequently Asked Questions
What is Tenvir 300 mg used for?
Tenvir 300 mg contains Tenofovir disoproxil fumarate and is associated with the treatment of HIV-1 infection as part of combination antiretroviral therapy. It may also be used for chronic hepatitis B where approved. The exact approved indications depend on the product label and clinician assessment.
What is the generic name of Tenvir 300 mg?
The generic name is Tenofovir disoproxil fumarate.
What is the strength of Tenvir listed on this page?
The supplied product information identifies Tenofovir disoproxil fumarate 300 mg. The exact formulation should be verified against the original product packaging.
Can Tenvir 300 mg be used alone to treat HIV?
No. For HIV-1 infection, Tenvir must be used with other appropriate antiretroviral medicines as part of a combination treatment regimen.
Does Tenvir 300 mg require medical supervision?
Yes. It is a prescription antiviral medicine that requires qualified medical oversight. Kidney function, hepatitis B status and potential medicine interactions may require monitoring.
Can treatment be stopped without medical advice?
No. Treatment should not be interrupted or discontinued without consulting the treating healthcare professional. Stopping treatment can cause complications, particularly in people with chronic hepatitis B.
Can international patients submit a Tenvir enquiry through Medinglobal?
International enquiries may be submitted. Any coordination or subsequent supply depends on confirmation by an authorised independent provider and compliance with applicable regulations in the relevant countries.
Does Medinglobal sell or dispense Tenvir directly?
No. Medinglobal provides product information, identification and enquiry coordination. It does not itself manufacture, sell, dispense or prescribe the medicine through the website.
Reviews
There are no reviews yet.